Jinwoo Shin

Jinwoo Shin

Auto-generated profile, based on publicly available information

Jinwoo Shin

Department of Chemistry, Korea University, Seoul, 02841, Korea

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 December 2020 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
CLChuang Liu
Chuang Liu
JSJinwoo Shin
Jinwoo Shin
SSSubin Son
Subin Son
YCYoumi Choe
Youmi Choe
NFNika Farokhzad
Nika Farokhzad
WTWei Tao
Wei Tao
Pnictogens (the non-metal phosphorus, metalloids arsenic and antimony, and metal bismuth) possess diverse chemical characteristics that support the formation of extended molecular structures. As witnessed by the centuries-old (and ongoing) clinical utilities, pnictogen-based compounds have secured their places in history as “magic bullet” therapeutic drugs in medicinal contexts. Moreover, with the development of recent metalloproteomics and bio-coordination chemistry, the pnictogen-based drugs functionally binding to proteins/enzymes in biological systems have been underlaid for “drug repurposing” with promising opportunities. Furthermore, advances in the modern materials science and nonotechnology have stimulated a revolution in other newly discovered forms of pnictogens—phosphorene, arsenene, antimonene, and bismuthine (layered pnictogens). Based on their favorable optoelectronic properties, layered pnictogens have shown dramatic superiority as emerging photonic nanomedicines for the treatment of various diseases. This tutorial review outlines the history and mechanism of action of ancient pnictogen-based drugs (e.g., arsenical compounds in traditional Chinese medicine) and their repurposing into modern therapeutics. Then, the revolutionary use of emerging layered pnictogens as photonic nanomedicines, alongside assessments of their in vivo biosafety, is discussed. Finally, the challenges to further development of pnictogens are set forth and insights for further exploration of their appealing properties are offered. This tutorial review may also provide some deep insights into the fields of integrated traditional Chinese and Western medicines from the perspective of materials science and nanotechnology.

20 June 2023 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
JSJinwoo Shin
Jinwoo Shin
NKNayeon Kang
Nayeon Kang
BKByungkook Kim
Byungkook Kim
HHHyunsik Hong
Hyunsik Hong
LYLe Yu
Le Yu
Jong Seung KimJong Seung Kim
Jong Seung Kim
One-dimensional (1-D) nanomaterials possess unique shape-dependent phyicochemical properties and are increasingly recognized as promising materials for nanotechnology. 1-D nanomaterials can be classified according to their shape, such as nanorods, nanotubes, nanowires, self-assembled nanochains, etc., and have been applied in electronics, photonics, and catalysis. The biological characteristics of 1-D nanomaterials, including high drug loading efficiency, prolonged blood circulation, the ability to capture cancer cells, unique cellular uptake mechanisms, efficient photothermal conversion, and material tunability, have aided in extending their potential to biomedical applications, particularly in cancer therapy and diagnosis. This review highlights a novel perspective on emerging 1-D nanomaterials for cancer therapy and diagnosis by introducing the definition of 1-D nanomaterials, their shape-dependent physicochemical properties, biomedical applications, and recent advances in cancer therapy and diagnosis. This review also proposes unexplored potential nanomaterial types and therapeutic applications for 1-D nanomaterials. In particular, the most significant and exciting advances in recent years, including ultrasound-enabled sonodynamic therapy, magnetic field-based therapy, and bioresponsive 1-D nanomaterials for intracellular self-assembly in situ, are discussed along with novel therapeutic concepts, such as piezoelectric 1-D nanomaterials, nanozyme-based nanomedicine, and others.

2 February 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
JAJusung An
Jusung An
KKKyeonghwan Kim
Kyeonghwan Kim
HLHo-Jae LIM
Ho-Jae LIM
HKHye Yun Kim
Hye Yun Kim
JSJinwoo Shin
Jinwoo Shin
Jong Seung KimJong Seung Kim
Jong Seung Kim
Amyloid-β (Aβ) oligomers are implicated in the onset of Alzheimer’s disease (AD). Herein, quinoline-derived half-curcumin-dioxaborine (Q-OB) fluorescent probe was designed for detecting Aβ oligomers by finely tailoring the hydrophobicity of the biannulate donor motifs in donor-π-acceptor structure. Q-OB shows a great sensing potency in dynamically monitoring oligomerization of Aβ during amyloid fibrillogenesis in vitro. In addition, we applied this strategy to fluorometrically analyze Aβ self-assembly kinetics in the cerebrospinal fluids (CSF) of AD patients. The fluorescence intensity of Q-OB in AD patients’ CSF revealed a marked change of log (I/I0) value of 0.34 ± 0.13 (cognitive normal), 0.15 ± 0.12 (mild cognitive impairment), and 0.14 ± 0.10 (AD dementia), guiding to distinguish a state of AD continuum for early diagnosis of AD. These studies demonstrate the potential of our approach can expand the currently available preclinical diagnostic platform for the early stages of AD, aiding in the disruption of pathological progression and the development of appropriate treatment strategies.

26 February 2019 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
JSJinwoo Shin
Jinwoo Shin
PVPeter Verwilst
Peter Verwilst
HCHayoung Choi
Hayoung Choi
SKSangrim Kang
Sangrim Kang
JIYOU HANJIYOU HAN
JIYOU HAN
Jong Seung KimJong Seung Kim
Jong Seung Kim

13 February 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
派刘派 刘
派 刘
WFWeiqiang Fu
Weiqiang Fu
PVPeter Verwilst
Peter Verwilst
MWMiae Won
Miae Won
JSJinwoo Shin
Jinwoo Shin
Jong Seung KimJong Seung Kim
Jong Seung Kim

17 March 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
JSJinwoo Shin
Jinwoo Shin
DKDong Won Kang
Dong Won Kang
JLJong Hyeon Lim
Jong Hyeon Lim
JAJong Min An
Jong Min An
YKYoungseo Kim
Youngseo Kim
Chang Seop HongChang Seop Hong
Chang Seop Hong
Engineering excitation wavelength of photosensitizers (PSs) for enhanced reactive oxygen species (ROS) generation has inspired new windows for opportunities, enabling investigation of previously impracticable biomedical and photocatalytic applications. However, controlling the wavelength corresponding to operating conditions remains challenging while maintaining high ROS generation. To address this challenge, we implement a wavelength-engineerable imidazolium-based porous organic photocatalytic ROS generation system (KUP system) via a cost-effective one-pot reaction. Remarkably, the optimal wavelength for maximum performance can be tuned by modifying the linker, generating ROS despite the absence of metal ions and covalently attached heavy atoms. We demonstrate that protonated polymerization exclusively enables photosensitization and closely interacts with oxygen related to the efficiency of photosensitizing. Furthermore, superior tumor eradication and biocompatibility of the KUP system were confirmed through bioassays. Overall, the results document an unprecedented polymerization method capable of engineering wavelength, providing a potential basis for designing nanoscale photosensitizers in various ROS-utilizing applications.